SCHEMBL18980129

SCHEMBL18980129

O=c1c(Cl)c(Cl)cnn1Cc1c(Cl)cccc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.69
▸ NPSR1 Q6W5P4 8/20 0.69
▸ SMN1; SMN2 Q16637 7/20 0.69
▸ POLB P06746 5/20 0.69
▸ MEN1 O00255 3/20 0.69
▸ KMT2A Q03164 3/20 0.69
▸ BLM P54132 1/20 0.69
▸ GPR35 Q9HC97 1/20 0.69
▸ ALDH1A1 P00352 14/20 0.61
▸ HTT P42858 12/20 0.61
▸ LMNA P02545 5/20 0.61
▸ CYP1A2 P05177 2/20 0.61
▸ CYP2C19 P33261 2/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ MITF O75030 5/20 0.60
▸ PKM P14618 1/20 0.60
▸ MAPT P10636 8/20 0.55
▸ RECQL P46063 2/20 0.55
▸ NPC1 O15118 7/20 0.51
▸ JAK2 O60674 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19000726 0.90 NPSR1 (0.61) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL19000708 0.87 HTT (0.60) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL19011573 0.86 RAB9A (0.60) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL19000703 0.86 NPBWR1 (0.64) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL10642561 0.82 RAB9A (1.00) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL1691901 0.81 HTT (0.71) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL18979940 0.78 RAB9A (0.62) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL19000706 0.78 HTT (0.77) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL15674013 0.76 HTT (0.59) RAB9ANPSR1SMN1; SMN2POLBMEN1
SCHEMBL19011761 0.76 HTT (0.71) RAB9ANPSR1SMN1; SMN2POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB RAB9A 3085/4885NPSR1 4642/4885SMN1; SMN2 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback